Allogeneic bone marrow transplantation in children failing prior autologous bone marrow transplantation

G. A. Hale, Xin Tong, E. Benaim, J. M. Cunningham, H. E. Heslop, E. M. Horwitz, W. Leung, R. J. Rochester, P. D. Shearer, D. K. Srivastava, J. P. Woodard, L. C. Bowman

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Twenty-three children with de novo acute myelogenous leukemia (AML) (n = 20), secondary AML (n = 1), or non-Hodgkin's lymphoma (NHL) (n = 2) underwent allogeneic bone marrow transplantation (alloBMT) for graft failure (n = 1) or recurrent malignancy (n = 22) between February 1992 and August 1999 following autologous BMT (ABMT). Induction chemotherapy was given to 14 patients and nine patients went directly to alloBMT. Five received marrow from matched siblings, 14 from matched unrelated donors and four from mismatched family members. Conditioning regimens included cyclophosphamide, cytarabine, and total body irradiation. Nine patients are alive disease-free between 627 and 2433 days (1.7-6.7 years) post BMT resulting in a 4-year DFS of 39%. Eight patients relapsed at a median of 206 days (range, 35-669 days) post alloBMT and all eventually died. Eight patients (two of whom also relapsed) died of RRT. Although RRT and relapse remain significant problems, a significant percentage of pediatric patients failing ABMT may be cured with alloBMT.

Original languageEnglish (US)
Pages (from-to)155-162
Number of pages8
JournalBone Marrow Transplantation
Issue number2
StatePublished - 2001


  • Allogeneic BMT
  • Autologous BMT
  • Graft-versus-host disease
  • Second transplant
  • Survival

ASJC Scopus subject areas

  • Hematology
  • Transplantation


Dive into the research topics of 'Allogeneic bone marrow transplantation in children failing prior autologous bone marrow transplantation'. Together they form a unique fingerprint.

Cite this